CytomX Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 02/17/2026 | 24.69 M | $105.17 M | 60.35% | 14.96% |
| VR ADVISER, LLC | 02/17/2026 | 15.56 M | $66.29 M | 0.00% | 9.43% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 9.68 M | $41.24 M | 0.00% | 5.87% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/17/2026 | 8.97 M | $38.20 M | 145.88% | 5.43% |
| VANGUARD GROUP INC | 01/29/2026 | 8.48 M | $36.11 M | -5.28% | 5.14% |
| COMMODORE CAPITAL LP | 02/17/2026 | 7.69 M | $32.77 M | 0.00% | 4.66% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 5.19 M | $22.11 M | 27.55% | 3.15% |
| STATE STREET CORP | 02/13/2026 | 5.14 M | $21.90 M | 697.07% | 3.12% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 4.25 M | $18.11 M | 0.00% | 2.58% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 4.18 M | $17.82 M | 3.40% | 2.53% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 3.87 M | $16.50 M | -1.04% | 2.35% |
| FINANCIAL ENGINES ADVISORS L.L.C. | 02/12/2026 | 3.83 M | $16.31 M | 177.17% | 2.32% |
| BLACKROCK, INC. | 02/12/2026 | 3.67 M | $15.63 M | 54.05% | 2.22% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 3.53 M | $15.02 M | -58.33% | 2.14% |
| IKARIAN CAPITAL, LLC | 02/18/2026 | 3.17 M | $13.52 M | -5.93% | 1.92% |
| VIVO CAPITAL, LLC | 02/13/2026 | 2.88 M | $12.29 M | 0.00% | 1.75% |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 2.51 M | $10.68 M | 100.00% | 1.52% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 2.46 M | $10.48 M | 449.62% | 1.49% |
| WOODLINE PARTNERS LP | 02/17/2026 | 2.34 M | $9.96 M | 0.00% | 1.42% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 1.56 M | $6.65 M | 113.89% | 0.95% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.53 M | $6.50 M | -2.78% | 0.92% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 1.29 M | $5.49 M | 185.87% | 0.78% |
| MARSHALL WACE, LLP | 02/13/2026 | 1.16 M | $4.93 M | 4.70% | 0.70% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 1.06 M | $4.52 M | 766.23% | 0.64% |
| STEMPOINT CAPITAL LP | 02/17/2026 | 1.04 M | $4.41 M | 100.00% | 0.63% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 981.60 K | $4.18 M | 266.97% | 0.59% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 900.00 K | $3.83 M | 0.00% | 0.55% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 894.66 K | $3.81 M | -27.68% | 0.54% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 876.31 K | $3.73 M | -12.83% | 0.53% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 856.06 K | $3.64 M | 30.95% | 0.52% |
| EXOME ASSET MANAGEMENT LLC | 02/13/2026 | 745.31 K | $3.17 M | 0.00% | 0.45% |
| 02/17/2026 | 700.00 K | $2.98 M | 100.00% | 0.42% | |
| JANE STREET GROUP, LLC | 02/12/2026 | 607.22 K | $2.59 M | 51.29% | 0.37% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 592.70 K | $2.52 M | -18.81% | 0.36% |
| FIRST TRUST ADVISORS LP | 02/13/2026 | 423.17 K | $1.80 M | 5.29% | 0.26% |
| NORTHERN TRUST CORP | 02/17/2026 | 415.18 K | $1.77 M | 6.54% | 0.25% |
| MORGAN STANLEY | 02/13/2026 | 401.19 K | $1.71 M | 25.65% | 0.24% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 385.97 K | $1.64 M | 100.00% | 0.23% |
| SCHULHOFF & CO INC | 02/11/2026 | 374.85 K | $1.60 M | 100.00% | 0.23% |
| UBS GROUP AG | 01/29/2026 | 370.74 K | $1.58 M | 1,128.91% | 0.22% |
| CITADEL ADVISORS LLC | 02/17/2026 | 342.30 K | $1.46 M | -80.99% | 0.21% |
| BARCLAYS PLC | 02/13/2026 | 336.53 K | $1.43 M | 22,485.57% | 0.20% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 335.52 K | $1.43 M | 738.81% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 328.25 K | $1.40 M | 29.92% | 0.20% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 316.97 K | $1.35 M | 7.97% | 0.19% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 289.65 K | $1.23 M | -79.11% | 0.18% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/13/2026 | 273.58 K | $1.17 M | 100.00% | 0.17% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 229.60 K | $988.98 K | 45.01% | 0.14% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 02/17/2026 | 206.53 K | $879.80 K | 0.00% | 0.13% |
| EAM INVESTORS, LLC | 02/12/2026 | 203.82 K | $868.29 K | 100.00% | 0.12% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CytomX Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 188 institutional investors and hedge funds held shares of CytomX Therapeutics Inc. The most heavily invested institutionals were:
UBS Group AG: 3.12 M
Jefferies Financial Group Inc.: 3.07 M
DIMENSIONAL FUND ADVISORS LP: 1.93 M
VANGUARD FIDUCIARY TRUST CO: 1.1 M
JANE STREET GROUP, LLC: 997,510
BNP PARIBAS ARBITRAGE, SNC: 606,275
87.31% of CytomX Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 158.23 M shares in the last 24 months. This purchase volume represents approximately $795.89 M in transactions.